Patents Assigned to Perfinity Biosciences, Inc.
  • Patent number: 10266819
    Abstract: The disclosure provides an innovative immobilized enzyme reactor working system that includes improved reactor formats, heating element, optimum buffers, filtration apparatus and collection componentry for easy to use sample preparation. The system provides enhanced recovery, improved reproducibility and parallel processing capabilities capable of quantitatively processing hundreds of difficult to digest samples simultaneously in a shortened period of time.
    Type: Grant
    Filed: January 30, 2014
    Date of Patent: April 23, 2019
    Assignee: PERFINITY BIOSCIENCES, INC.
    Inventors: Kevin Wayne Meyer, John Patrick O'Grady, Robert Harold Ellis, Nicholas Brian Herold, Derrick Nathaniel Poe
  • Publication number: 20150361415
    Abstract: The disclosure provides an innovative immobilized enzyme reactor working system that includes improved reactor formats, heating element, optimum buffers, filtration apparatus and collection componentry for easy to use sample preparation. The system provides enhanced recovery, improved reproducibility and parallel processing capabilities capable of quantitatively processing hundreds of difficult to digest samples simultaneously in a shortened period of time.
    Type: Application
    Filed: January 30, 2014
    Publication date: December 17, 2015
    Applicant: Perfinity Biosciences, Inc.
    Inventors: Kevin Wayne MEYER, John Patrick O'GRADY, Robert Harold ELLIS, NICHOLAS Brian HEROLD, Derrick Nathaniel POE
  • Patent number: 8455202
    Abstract: A multi-dimensional method for simultaneously analyzing multiple analytes within a sample solution, comprising adding affinity selectors to a sample solution containing analytes to be measured, the affinity selectors having an affinity for one or more of the analytes within the sample solution; allowing immune complexes to form between the affinity selectors and the analytes; partially or totally resolving the formed immune complexes from non-analyte substances within the sample solution; dissociating the resolved immune complexes; separating the analytes and the affinity selectors of the dissociated immune complexes from one another by capturing the analytes through a surface adsorption process; transferring the captured analytes to a detection means; and resolving the analytes with the detection means in accordance with their mass-to-charge ratios.
    Type: Grant
    Filed: March 10, 2010
    Date of Patent: June 4, 2013
    Assignee: Perfinity Biosciences, Inc.
    Inventors: Fred E. Regnier, Nicholas B. Herold, Kevin W. Meyer